Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Ondansetron for the Treatment of Methamphetamine Dependence - 1
This study has been completed.
Study NCT00040053 Information provided by National Institute on Drug Abuse (NIDA)
First Received: June 18, 2002 Last Updated: July 21, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amphetamine-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Ondansetron
Additional drug interventions recognized in this trial
Amphetamine
Methamphetamine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Anti-Anxiety Agents
Antiemetics
Antipruritics
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Central Nervous System Stimulants
Dermatologic Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Antagonists
Sympathomimetics
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
University of Texas
Back to top of Main Content
